Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Atrial fibrillation (AF) is associated with an increased risk of stroke, and the use
of oral anticoagulation reduces stroke and all-cause mortality. Geographical differences
may exist in AF risk factors, risk stratification and treatment strategies.
[1
]
University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham,
UK; Department of Internal Medicine and Medical Specialties, Sapienza-University of
Rome, Rome, Italy. Electronic address: marco.proietti@uniroma1.it.
[2
]
University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham,
UK; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University,
Aalborg, Denmark. Electronic address: g.y.h.lip@bham.ac.uk.